Literature DB >> 22834919

The potential prognostic role of cardiovascular autonomic failure in α-synucleinopathies.

A Fanciulli1, S Strano, C Colosimo, C Caltagirone, G Spalletta, F E Pontieri.   

Abstract

Cardiovascular autonomic failure is the second most common dysautonomic feature of α-synucleinopathies and has significant impact on daily activities and quality of life. Here we provide a systematic review of cardiovascular autonomic failure in α-synucleinopathies, emphasizing its impact on cognitive functions and disease outcomes. Articles spanning the period between January 1985 and April 2012 were identified from the PubMed database using a keyword-based search. Epidemiological studies highlight the negative prognostic effect of cardiovascular autonomic failure on cardiovascular and cerebrovascular outcomes and overall mortality in all α-synucleinopathies. Altered cerebral perfusion, vascular pressure stress, and related disruption of the blood-brain barrier may also contribute to the white matter hyperintensities and cognitive dysfunction frequently found in patients affected by neurocardiovascular instability. These findings support the hypothesis that cardiovascular autonomic failure may play a negative prognostic role in α-synucleinopathies and suggest that precocious screening and therapeutic management of cardiovascular autonomic failure may positively impact disease course.
© 2012 The Author(s) European Journal of Neurology © 2012 EFNS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22834919     DOI: 10.1111/j.1468-1331.2012.03819.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  24 in total

1.  Orthostatic hypotension predicts motor decline in early Parkinson disease.

Authors:  Vikas Kotagal; Christina Lineback; Nicolaas I Bohnen; Roger L Albin
Journal:  Parkinsonism Relat Disord       Date:  2016-09-09       Impact factor: 4.891

2.  Orthostatic hypotension acutely impairs executive functions in Parkinson's disease.

Authors:  Michela Sforza; Francesca Assogna; Domiziana Rinaldi; Giuliano Sette; Stefania Tagliente; Francesco E Pontieri
Journal:  Neurol Sci       Date:  2018-04-07       Impact factor: 3.307

3.  Survival in synucleinopathies: A prospective cohort study.

Authors:  David S Goldstein; Courtney Holmes; Yehonatan Sharabi; Tianxia Wu
Journal:  Neurology       Date:  2015-10-02       Impact factor: 9.910

Review 4.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

5.  A Review on the Clinical Diagnosis of Multiple System Atrophy.

Authors:  Iva Stankovic; Alessandra Fanciulli; Victoria Sidoroff; Gregor K Wenning
Journal:  Cerebellum       Date:  2022-08-19       Impact factor: 3.648

Review 6.  Sympathetic neuroimaging.

Authors:  David S Goldstein
Journal:  Handb Clin Neurol       Date:  2013

7.  Supine hypertension in Parkinson's disease and multiple system atrophy.

Authors:  Alessandra Fanciulli; Georg Göbel; Jean Pierre Ndayisaba; Roberta Granata; Susanne Duerr; Stefano Strano; Carlo Colosimo; Werner Poewe; Francesco E Pontieri; Gregor K Wenning
Journal:  Clin Auton Res       Date:  2016-01-22       Impact factor: 4.435

Review 8.  Pure Autonomic Failure.

Authors:  Pariwat Thaisetthawatkul
Journal:  Curr Neurol Neurosci Rep       Date:  2016-08       Impact factor: 5.081

9.  Detecting nocturnal hypertension in Parkinson's disease and multiple system atrophy: proposal of a decision-support algorithm.

Authors:  Alessandra Fanciulli; Stefano Strano; Jean Pierre Ndayisaba; Georg Goebel; Laura Gioffrè; Massimiliano Rizzo; Carlo Colosimo; Carlo Caltagirone; Werner Poewe; Gregor K Wenning; Francesco E Pontieri
Journal:  J Neurol       Date:  2014-04-16       Impact factor: 4.849

10.  Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue?

Authors:  Giovanna Calandra-Buonaura; Pietro Guaraldi; Luisa Sambati; Giovanna Lopane; Annagrazia Cecere; Giorgio Barletta; Federica Provini; Manuela Contin; Paolo Martinelli; Pietro Cortelli
Journal:  Neurol Sci       Date:  2013-06-01       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.